Farmakokinetikken hos disse lægemidler, som secerneres af det samme renale system, herunder transportproteinerne (hOAT) 1 og 3 eller MRP 4, kan derfor forandre sig, hvis de indgives samtidig.
Consequently, the pharmacokinetics of these medicinal products which are secreted by the same renal pathway including transport proteins hOAT 1 and 3 or MRP 4 might be modified if they are co-administered.